[Pharmacogenetics and tailored drug therapy]
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
[Pharmacogenetics and tailored drug therapy]. / Nielsen, F.C.; Borregaard, N.
I: Ugeskrift for læger, Bind 171, Nr. 10, 2009, s. 790-794.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - [Pharmacogenetics and tailored drug therapy]
AU - Nielsen, F.C.
AU - Borregaard, N.
N1 - Cochrane: Statusart., ok. Vi har downloadet denne reference igen, da afd. har downloadet ref. med forkert filter. Cochrane: Den danske tekst klippet hertil, Farmakogenetik og skræddersyet medicinsk behandling, og den downloadede engelske tekst sat i titel.
PY - 2009
Y1 - 2009
N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology Udgivelsesdato: 2009/3/2
AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology Udgivelsesdato: 2009/3/2
M3 - Tidsskriftartikel
VL - 171
SP - 790
EP - 794
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 10
ER -
ID: 19797762